These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2188754)

  • 1. Assessment of renin dependency of hypertension with a dipeptide renin inhibitor.
    Weber MA; Neutel JM; Essinger I; Glassman HN; Boger RS; Luther R
    Circulation; 1990 Jun; 81(6):1768-74. PubMed ID: 2188754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of enalkiren, a novel, dipeptide renin inhibitor.
    Glassman HN; Kleinert HD; Boger RS; Moyse DM; Griffiths AN; Luther RR
    J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S76-81. PubMed ID: 1705633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged duration of blood pressure response to enalkiren, the novel dipeptide renin inhibitor, in essential hypertension.
    Boger RS; Glassman HN; Cavanaugh JH; Schmitz PJ; Lamm J; Moyse D; Cohen A; Kleinert HD; Luther RR
    Hypertension; 1990 Jun; 15(6 Pt 2):835-40. PubMed ID: 2190927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat.
    Neutel JM; Luther RR; Boger RS; Weber MA
    Am Heart J; 1991 Oct; 122(4 Pt 1):1094-100. PubMed ID: 1656720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
    Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR
    J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients.
    Denolle T; Luo P; Guyene TT; Cazaubon C; Sissmann J; Corvol P; Ménard J
    Arzneimittelforschung; 1993 Feb; 43(2A):255-9. PubMed ID: 8498973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renin inhibition in systemic hypertension.
    Anderson PW; Do YS; Schambelan M; Horton R; Boger RS; Luther RR; Hsueh WA
    Am J Cardiol; 1990 Dec; 66(19):1342-7. PubMed ID: 2244565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a novel renin inhibitor in patients with essential hypertension.
    Bursztyn M; Gavras I; Tifft CP; Luther R; Boger R; Gavras H
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):493-500. PubMed ID: 1691375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remikiren (Ro 42-5892)--an orally active renin inhibitor in essential hypertension. Effects on blood pressure and the renin-angiotensin-aldosterone system.
    Himmelmann A; Bergbrant A; Svensson A; Hansson L; Aurell M
    Am J Hypertens; 1996 Jun; 9(6):517-22. PubMed ID: 8783774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-relationship of sympathetic nervous system and renin-angiotensin-aldosterone system in three renin subgroups of borderline and persistent essential hypertension.
    Mikami K; Nishikawa T; Tamura Y; Kumagai A
    Clin Exp Hypertens (1978); 1981; 3(6):1091-107. PubMed ID: 7037336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of renin-angiotensin system activation by dietary sodium restriction and upright position on plasma leptin concentration in patients with essential hypertension.
    Adamczak M; Kokot F; Chudek J; Wiecek A
    Med Sci Monit; 2002 Jul; 8(7):CR473-7. PubMed ID: 12118193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
    Ocón J; Mora-Macià J; Castellet R; del Río G
    Med Clin (Barc); 1994 Jan; 102(2):41-5. PubMed ID: 8133694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system.
    Dahlöf B; Herlitz H; Aurell M; Hansson L
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):900-11. PubMed ID: 1337459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin--angiotensin antagonists and the regulation of blood pressure.
    Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
    Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin inhibitors in hypertension.
    Luther RR; Glassman HN; Boger RS
    Clin Nephrol; 1991 Oct; 36(4):181-6. PubMed ID: 1959244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension.
    van den Meiracker AH; Admiraal PJ; Man in 't Veld AJ; Derkx FH; Ritsema van Eck HJ; Mulder P; van Brummelen P; Schalekamp MA
    BMJ; 1990 Jul; 301(6745):205-10. PubMed ID: 2203486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin inhibition with A-64662: effect on blood pressure and hormonal response in man.
    Bursztyn M; Gavras I; Tifft CP; Bauer JH; Melby JC; Gavras H
    J Hypertens Suppl; 1989 Dec; 7(6):S306-7. PubMed ID: 2698944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyridamole decreases circulating renin-angiotensin system activity in hypertensive patients.
    Taddei S; Arzilli F; Arrighi P; Salvetti A
    Am J Hypertens; 1992 Jan; 5(1):29-31. PubMed ID: 1736931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.